Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines

By Mike Evers

Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines
The company declined in the mid-single digits due to COVID-related headwinds and inventory stocking declines in its orthobiologics franchise.

Member-Only Content

SUBSCRIBE Login

Product Labels: Traditional Soft Tissue Repair, Orthobiologic Soft Tissue Repair, Viscosupplement

Tags: Revenue Report